Clinical Trial

HC010 in First-line PD-L1 Positive Advanced NSCLC Patients

Name: HC010 in First-line PD-L1 Positive Advanced NSCLC Patients — clinical trial record (NCT07169552)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Phase 2 clinical study to evaluate the efficacy, safety, pharmacokinetics and immunogenicity profile of HC010 for injection in patients with positive PD-L1 (TPS ≥1%)

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-05.

Status change: Not Yet Recruiting → Recruiting 2025-12-09

Trial Details

NCT Number	NCT07169552
Lead Sponsor	HC Biopharma Inc.
Conditions	NSCLC
Enrollment	50 participants
Start Date	2025-12-09
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-12-17